Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
8.45
-0.19 (-2.20%)
Jun 12, 2025, 4:00 PM - Market closed
Evolent Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -108.96 | -61.62 | -113.04 | -19.16 | -37.6 | -334.25 | Upgrade
|
| Depreciation & Amortization | 86.23 | 91.67 | 96.72 | 40.2 | 33.54 | 36.58 | Upgrade
|
| Other Amortization | 34.25 | 33.95 | 41.46 | 52.36 | 57.59 | 60.28 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 8.11 | - | -45.94 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.69 | 3.69 | 24.07 | - | - | 215.1 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 47.13 | Upgrade
|
| Loss (Gain) on Equity Investments | 3.77 | 3.44 | -1.29 | -4.57 | -13.18 | -10.04 | Upgrade
|
| Stock-Based Compensation | 32.04 | 39.75 | 40.5 | 33.98 | 16.71 | 14.61 | Upgrade
|
| Other Operating Activities | 68.67 | 24.46 | 24.18 | -7.88 | 34.49 | 8.39 | Upgrade
|
| Change in Accounts Receivable | -2.76 | 32.06 | -164.69 | -102.98 | -5.78 | -47.02 | Upgrade
|
| Change in Accounts Payable | 15.93 | 4.25 | -6.72 | 13.17 | 7.25 | 3.55 | Upgrade
|
| Change in Unearned Revenue | -1.12 | -3.47 | -0.26 | -6.51 | -0.74 | -8.94 | Upgrade
|
| Change in Other Net Operating Assets | -113.31 | -149.4 | 193.57 | -10.62 | -14.38 | -2.91 | Upgrade
|
| Operating Cash Flow | 18.42 | 18.77 | 142.58 | -11.55 | 38.75 | -16.23 | Upgrade
|
| Operating Cash Flow Growth | -88.15% | -86.84% | - | - | - | - | Upgrade
|
| Capital Expenditures | -39.48 | -33.12 | -28.75 | -47.53 | -27.5 | -32.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.58 | - | 3.49 | - | Upgrade
|
| Cash Acquisitions | -19.5 | -19.5 | -388.25 | -248.11 | -46.5 | 159.76 | Upgrade
|
| Investment in Securities | -7.31 | -10.31 | 0.87 | 5.55 | 11.72 | 132.27 | Upgrade
|
| Other Investing Activities | - | - | - | 30.97 | 43 | 0.11 | Upgrade
|
| Investing Cash Flow | -66.29 | -62.93 | -415.54 | -259.12 | -15.79 | 261.07 | Upgrade
|
| Long-Term Debt Issued | - | 58.58 | 647.49 | 219.74 | - | 30.06 | Upgrade
|
| Long-Term Debt Repaid | - | - | -464.2 | - | -98.85 | -16.61 | Upgrade
|
| Net Debt Issued (Repaid) | 217.61 | 58.58 | 183.29 | 219.74 | -98.85 | 13.46 | Upgrade
|
| Issuance of Common Stock | 2.4 | 3.46 | 12.52 | 4.45 | 13.29 | 2.58 | Upgrade
|
| Repurchase of Common Stock | -5.96 | -15.7 | -15.29 | -18.32 | -3.85 | -1.85 | Upgrade
|
| Preferred Dividends Paid | -19.58 | -20.09 | -18.79 | - | - | - | Upgrade
|
| Dividends Paid | -19.58 | -20.09 | -18.79 | - | - | - | Upgrade
|
| Other Financing Activities | -102.06 | -26.82 | -48.39 | -74.33 | 59.86 | -26.04 | Upgrade
|
| Financing Cash Flow | 92.41 | -0.57 | 281.34 | 131.54 | -29.55 | -11.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.17 | -0.23 | -0.08 | -0.66 | -0.05 | 0.07 | Upgrade
|
| Net Cash Flow | 44.37 | -44.96 | 8.3 | -139.78 | -6.64 | 233.05 | Upgrade
|
| Free Cash Flow | -21.06 | -14.35 | 113.84 | -59.08 | 11.25 | -48.29 | Upgrade
|
| Free Cash Flow Margin | -0.88% | -0.56% | 5.80% | -4.37% | 1.24% | -5.22% | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.13 | 1.02 | -0.63 | 0.13 | -0.57 | Upgrade
|
| Cash Interest Paid | 20.21 | 20.21 | 53.59 | 6.27 | 7.11 | 13.35 | Upgrade
|
| Cash Income Tax Paid | 1.39 | 1.39 | 4.89 | 1.4 | 0.55 | 9.68 | Upgrade
|
| Levered Free Cash Flow | 2.23 | -41 | 172.48 | 12.57 | 93.58 | 122.65 | Upgrade
|
| Unlevered Free Cash Flow | 16.6 | -29.1 | 202.54 | 20 | 91.42 | 125.58 | Upgrade
|
| Change in Net Working Capital | 91.5 | 159.25 | -37.19 | 44.28 | -40.01 | -80.22 | Upgrade
|
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.